Skip to main content
logo
Ceryvyn Therapeutics Limited (ASX:CYV)
Australia flag Australia · Delayed Price · Currency is AUD
0.0110
0.00 (0.00%)
Aug 26, 2026, 4:10 PM AEST

Ceryvyn Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
15739382257387469
Market Cap Growth
-97.96%93.39%48.68%-33.67%-17.33%-26.23%
Enterprise Value
-18886417178266266
Last Close Price
0.010.600.350.480.961.16

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-109.83109.83109.83109.83109.83
PS Ratio
-748.013317.43972.82443.861341.133676.31
PB Ratio
0.45-2.41-3.36-29.225.562.60
P/TBV Ratio
0.45---5.562.60

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
-3976.551061.86307.67921.142088.86

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
--1.23-2.65-14.67-0.00
Net Debt / Equity Ratio
-0.98-0.99-0.370.57-0.93-0.87
Net Debt / EBITDA Ratio
0.30-1.27-0.150.020.462.98
Net Debt / FCF Ratio
0.24-1.25-0.170.030.632.59
Asset Turnover
-0.000.000.010.000.00
Quick Ratio
18.560.222.885.114.2539.83
Current Ratio
19.520.222.945.254.9744.46
Return on Equity (ROE)
----676.67%-101.29%-50.42%
Return on Assets (ROA)
-50.44%-79.28%-83.43%-118.18%-60.81%-26.38%
Return on Capital Employed (ROCE)
-324.40%77.50%-153.80%-187.80%-201.10%-29.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
1973.51%-33.61%-86.41%-83.34%-34.78%-12.91%
FCF Yield
-902.48%-32.76%-63.19%-70.54%-26.73%-12.97%
Buyback Yield / Dilution
-34.62%-91.90%-44.18%-25.91%-9.71%-22.87%